flex analysis version 2.2 software (Bruker Corporation)
90
Structured Review
Bruker Corporation
flex analysis version 2.2 software
Flex Analysis Version 2.2 Software, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flex+analysis+version+2%2E2+software/software+flex+analysis+version+2+2/pm31519070-82-19-22
Average 90 stars, based on 1 article reviews
Flex Analysis Version 2.2 Software, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flex+analysis+version+2%2E2+software/software+flex+analysis+version+2+2/pm31519070-82-19-22
Average 90 stars, based on 1 article reviews
flex analysis version 2.2 software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Labeling:Article Title: Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease. Article Snippet: RATIONALE: Changes of the lipid composition might be associated with the onset and progression of various neurodegenerative diseases.. Herein, we investigated the changes in the plasma phosphatidylcholine (PC)/lysophosphatidylcholine (LPC) ratios in patients with Parkinson’s disease (PD) in comparison to healthy subjects and their correlation with clinicopathological features.. METHODS: The study included 10 controls and 25 patients with PD. Article Title: Identification of Two Proteins Associated with Mammalian ATP Synthase Article Snippet: Analysis of Mass Spectrometric Data—All MS spectra were smoothed, noise-filtered, and monoisotopically labeled using Flex Software:Article Title: Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease. Article Snippet: RATIONALE: Changes of the lipid composition might be associated with the onset and progression of various neurodegenerative diseases.. Herein, we investigated the changes in the plasma phosphatidylcholine (PC)/lysophosphatidylcholine (LPC) ratios in patients with Parkinson’s disease (PD) in comparison to healthy subjects and their correlation with clinicopathological features.. METHODS: The study included 10 controls and 25 patients with PD. Article Title: Identification of Two Proteins Associated with Mammalian ATP Synthase Article Snippet: Analysis of Mass Spectrometric Data—All MS spectra were smoothed, noise-filtered, and monoisotopically labeled using Flex |